Morphine Sulfate Injection · #6 of 35 active shortages by FDA posting duration
Brand: MORPHINE SULFATE
FDA lists Morphine Sulfate Injection as To Be Discontinued (Hospira, Inc., a Pfizer Company).
No availability text on this FDA row.
Morphine Sulfate Injection: To Be Discontinued
FDA availability text is not recorded on this row. 27 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Morphine Sulfate Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0409-1891-23)
- Package NDC
- 0409-1891-23
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jul 8, 2025
- Last Updated
- Jul 8, 2025
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
morphine
Side effects, interactions, warnings & more
Nearby, Other Morphine Shortage Records
Morphine Sulfate Injection
Piramal Critical Care Inc.
Injection
Morphine Sulfate Injection
Piramal Critical Care Inc.
Injection
Morphine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
Morphine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.